Insiders bought 46K on the open market and sold nothing.
Get an email when NAGE's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Ozan Pamir Chief Financial Officer | Bought 2 parts | 6,685 | $6.82 average | 46K | 230% | Form 4 |
| Mar 7, 2025 | Carlos Luis Lopez SVP, General Counsel | Bought | 273 | $7.86 | 2K | 14% | Form 4 |
| Dec 13, 2024 | Frank L Jaksch Jr Director | SoldNo plan | 37,161 | $6.19 | 230K | 1.6% | Form 4 |
| Nov 22, 2024 | Ozan Pamir Chief Financial Officer | Bought | 2,907 | $7.36 | 21K | New | Form 4 |
- Nov 14, 2025Ozan PamirChief Financial Officer · bought 6,685 at avg $6.8246K230% of stake
- Mar 7, 2025Carlos Luis LopezSVP, General Counsel · bought 273 at $7.862K14% of stake
- Dec 13, 2024No planFrank L Jaksch JrDirector · sold 37,161 at $6.19230K1.6% of stake
- Nov 22, 2024Ozan PamirChief Financial Officer · bought 2,907 at $7.3621KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Medicinal Chemicals & Botanical Products · Pick stocks to compare with NAGE
Held by ETFs
NAGE is in 14 US ETFs. The largest of them, with NAGE's weight in each:
Spot a number that looks wrong? Check it in NAGE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NAGE
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.